Skip to main content

 

DMD Advocates has advised HBM Healthcare Investments and other associated investors in leading OneSource Specialty Pharma’s $100 million fundraising through a pre-listing round, with DSK Legal representing OneSource on the deal. 

OneSource Specialty Pharma (formerly known as Stelis Biopharma), a contract development and manufacturing organisation (CDMO) platform, is an associate of Strides Pharma and its shares are to be listed shortly. 

The capital raised will support OneSource's growth, advance its research and development efforts, and expand its product offerings, which will strengthen the company's market position ahead of its initial public offering (IPO), according to a company statement.

The healthcare sector remains busy with dealmaking and private equity in the country, with $3.8 billion in deal value recorded in 2024. This figure includes Mankind Pharma's $1.6 billion acquisition of Bharat Serums and Vaccines.

The DMD team involved in the deal was led by partners Ayesha Rai and Vihang Virkar, with contributions from principal associate Pooja Shah and associate Vanshikha Choraria.

 

TO CONTACT EDITORIAL TEAM, PLEASE EMAIL ALBEDITOR@THOMSONREUTERS.COM

Related Articles

Trilegal, AZB act on Akasa Air’s latest fundraise led by Premji Invest

by Nimitt Dixit |

Trilegal has advised Akasa Air on its latest fundraise led by Premji Invest, Claypond Capital, and 360 ONE, which were all represented by AZB & Partners in separate mandates.

Trilegal, Touchstone, CAM act on Carlyle’s $400 mln entry into India auto-components space

by Nimitt Dixit |

Trilegal has advised global private equity firm Carlyle on its acquisition of majority stakes in Highway Industries (HIL) and Roop Automotives for $400 million, marking its entry into India's auto components sector through a new manufacturing platform.

JSA, CAM, Khaitan act on $2.3 bln Ayana Renewable sale

by Nimitt Dixit |

Indian law firm JSA Advocates & Solicitors has advised ONGC NTPC Green on its $2.3 billion acquisition of Ayana Renewable Power from National Investment and Infrastructure Fund (NIIF), British International Investment and private equity firm Eversource Capital.